| Gastroenterology Specialists Of Oregon Pc | |
|
1508 Division St Suite 15 Oregon City OR 97045-1583 | |
| (503) 657-5555 | |
| (503) 657-6502 |
| Full Name | Gastroenterology Specialists Of Oregon Pc |
|---|---|
| Speciality | Internal Medicine - Gastroenterology |
| Location | 1508 Division St, Oregon City, Oregon |
| Authorized Official Name and Position | Barbara G Tauscher (EXECUTIVE DIRECTOR) |
| Authorized Official Contact | 9712242457 |
| Accepts Medicare Insurance | This clinic does not participate in Medicare Program. |
| Mailing Address | Practice Location Address |
|---|---|
| Gastroenterology Specialists Of Oregon Pc 1508 Division St Suite 15 Oregon City OR 97045-1583 Ph: (503) 657-5555 | Gastroenterology Specialists Of Oregon Pc 1508 Division St Suite 15 Oregon City OR 97045-1583 Ph: (503) 657-5555 |
| NPI Number | 1164464616 |
|---|---|
| Provider Enumeration Date | 06/11/2006 |
| Last Update Date | 09/13/2007 |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1164464616 | NPI | - | NPPES |
| 171447 | Medicaid | OR |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RG0100X | Internal Medicine - Gastroenterology | (* (Not Available)) | Primary |
News Archive
Researchers at The Ohio State University College of Medicine are the first to identify an immune cell that may predict a transplant patient's risk of developing antibodies that can cause organ rejection.
Around one in four Montrealers take some kind of anti-depressant, and according to new research, the drugs are passing into the waterways and affecting fish. The findings are internationally significant as the city's sewage treatment system is similar to that in use in other major cities, and moreover, it is reputed to be the third largest treatment system in the world.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that it has initiated dosing in its Phase I clinical trial with ALN-TTR02, an RNAi therapeutic targeting the transthyretin (TTR) gene for the treatment of TTR-mediated amyloidosis (ATTR). The study is aimed at evaluating the safety and tolerability of ALN-TTR02 in healthy volunteers.
Ipsen today announced new governance in the United States, following its recently announced decision to launch Somatuline for oncology indications. Marc de Garidel will personally oversee this projected launch.
The FDA is right - when it comes to disease culprits, cigarette smoking tops the list. While recognized as the number-one cause of preventable disease and death, it's an incredibly tough habit to break due to the addictiveness of nicotine.
› Verified 8 days ago
Oregon City Family Practice Clinic,p.c. Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 1420 John Adams St, Oregon City, OR 97045 Phone: 503-656-1484 Fax: 503-650-1976 | |
24 On Physicians Pc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1500 Division St, Oregon City, OR 97045 Phone: 503-656-1631 | |
Samuel Sabo Do Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 18171 Waldow Rd, Oregon City, OR 97045 Phone: 503-655-6044 Fax: 503-575-9171 | |
Pmg/oregon City Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1510 Division St Ste 200, Oregon City, OR 97045 Phone: 503-650-6880 Fax: 503-650-6888 | |
Providence Medical Group Oregon City Spine Center Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1510 Division St, Ste 170, Oregon City, OR 97045 Phone: 503-650-6288 Fax: 503-650-6884 | |
Oregon City Wellness & Family Medicine Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 1230 Division St, Oregon City, OR 97045 Phone: 503-655-5327 Fax: 503-722-4499 |